Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Welsh

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 21, 2016
Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation TherapyKamran A Ahmed, Jimmy J Caudell, Ghassan El-Haddad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine ProteomicsScott M Haake, Jiannong Li, Yun Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2021
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic CancerAslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, et al.
The Journal of Molecular Diagnostics : JMD|May 22, 2024
Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical CareAileen Y Alontaga, Pedro Cano, Hilal Ozakinci, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2018
Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation DoseKamran A Ahmed, Jacob G Scott, John A Arrington, et al.
Journal of the National Cancer Institute|December 4, 2014
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancerChunxia Cao, Ruli Gao, Min Zhang, et al.
Cell Chemical Biology|July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual TargetsNatalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|June 21, 2016
Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation TherapyKamran A Ahmed, Jimmy J Caudell, Ghassan El-Haddad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine ProteomicsScott M Haake, Jiannong Li, Yun Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2021
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic CancerAslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, et al.
The Journal of Molecular Diagnostics : JMD|May 22, 2024
Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical CareAileen Y Alontaga, Pedro Cano, Hilal Ozakinci, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2018
Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation DoseKamran A Ahmed, Jacob G Scott, John A Arrington, et al.
Journal of the National Cancer Institute|December 4, 2014
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancerChunxia Cao, Ruli Gao, Min Zhang, et al.
Cell Chemical Biology|July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual TargetsNatalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
Pageof 7